Moderna Revenue Triples on Soaring Vaccine Sales

The biotechnology company’s revenue topped $6 billion in its latest quarter, beating analyst expectations, driven almost entirely by sales of its mRNA-based vaccine.

The biotechnology company’s revenue topped $6 billion in its latest quarter, beating analyst expectations, driven almost entirely by sales of its mRNA-based vaccine.

Source: Read More

PAID

Leave a Comment